Introducing Claude Science, the AI platform designed to expedite the discovery of promising new therapies. Anthropic will ...

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

Scientists have finally uncovered how bacteria naturally create multiple versions of powerful anti-cancer drugs, solving a mystery that has frustrated researchers for decades.

A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...

Monday - Friday, 6:00 - 7:00 PM ET AstraZeneca CEO Pascal Soriot said artificial intelligence is helping the company develop medicines faster, identify promising drug targets, and improve the odds of ...

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...

Trying to get medicine approved by the US Food and Drug Administration often feels like buying an expensive lottery ticket, with the uncertain prospect of a reward years away. It takes about a decade ...

Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report on the global effort to find a cure for Alzheimer's. The work is published ...

The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...

Let’s start this story with a sing-along to the tune of “My Favorite Things.” Foundayo, Mounjaro, Zepbound and Ozempic. Skyrizi, Wegovy, Rinvoq and Dupixent. Tremfya, Jardiance, Nurtec ODT. These are ...

AWS has now unveiled Amazon Bio Discovery, an AI platform that grants researchers direct access to a broad library of biological foundation models that can be fine-tuned for specific use cases in drug ...

LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab, which has fallen behind Eli Lilly (LLY.N), opens new tab in the immensely lucrative weight-loss drug market, said ...